Balasubramanian Sendhil K, Tiruvoipati Ravindranath, Amin Mohammed, Aabideen Kanakkande K, Peek Giles J, Sosnowski Andrew W, Firmin Richard K
Department of ECMO, Glenfield General Hospital, Leicester, LE3 9QQ, UK.
J Cardiothorac Surg. 2007 Jan 11;2:4. doi: 10.1186/1749-8090-2-4.
Veno-arterial extracorporeal membrane oxygenation (ECMO) is a common modality of circulatory assist device used in children. We assessed the outcome of children who had ECMO following repair of congenital cardiac defects (CCD) and identified the risk factors associated with hospital mortality.
From April 1990 to December 2003, 53 patients required ECMO following surgical correction of CCD. Retrospectively collected data was analyzed with univariate and multivariate logistic regression analysis.
Median age and weight of the patients were 150 days and 5.4 kgs respectively. The indications for ECMO were low cardiac output in 16, failure to wean cardiopulmonary bypass in 13, cardiac arrest in 10 and cardio-respiratory failure in 14 patients. The mean duration of ECMO was 143 hours. Weaning off from ECMO was successful in 66% and of these 83% were survival to hospital-discharge. 37.7% of patients were alive for the mean follow-up period of 75 months. On univariate analysis, arrhythmias, ECMO duration >168 hours, bleeding complications, renal replacement therapy on ECMO, arrhythmias and cardiac arrest after ECMO were associated with hospital mortality.On multivariate analysis, abnormal neurology, bleeding complications and arrhythmias after ECMO were associated with hospital mortality. Extra and intra-thoracic cannulations were used in 79% and 21% of patients respectively and extra-thoracic cannulation had significantly less bleeding complications (p = 0.031).
ECMO provides an effective circulatory support following surgical repair of CCD in children. Extra-thoracic cannulation is associated with less bleeding complications. Abnormal neurology, bleeding complications on ECMO and arrhythmias after ECMO are poor prognostic indicators for hospital survival.
静脉 - 动脉体外膜肺氧合(ECMO)是用于儿童的一种常见循环辅助装置方式。我们评估了先天性心脏缺陷(CCD)修复术后接受ECMO治疗的儿童的预后,并确定了与医院死亡率相关的危险因素。
1990年4月至2003年12月,53例患者在CCD手术矫正后需要ECMO。对回顾性收集的数据进行单因素和多因素逻辑回归分析。
患者的中位年龄和体重分别为150天和5.4千克。ECMO的适应证为16例心输出量低、13例体外循环脱机失败、10例心脏骤停和14例心肺衰竭。ECMO的平均持续时间为143小时。66%的患者成功撤离ECMO,其中83%存活至出院。37.7%的患者在平均75个月的随访期内存活。单因素分析显示,心律失常、ECMO持续时间>168小时、出血并发症、ECMO期间的肾脏替代治疗、ECMO后的心律失常和心脏骤停与医院死亡率相关。多因素分析显示,神经功能异常、出血并发症和ECMO后的心律失常与医院死亡率相关。分别有79%和21%的患者采用了胸外和胸内插管法,胸外插管法的出血并发症明显较少(p = 0.031)。
ECMO为儿童CCD手术修复后提供了有效的循环支持。胸外插管法出血并发症较少。神经功能异常、ECMO时的出血并发症和ECMO后的心律失常是医院生存不良预后指标。